Our Mission
GBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care.
With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help eradicate COVID-19 and change the lives of people living with diabetes.
Latest News
Patients Living With Diabetes Voice Eagerness for ‘Finger-Prick’ Alternative in Global Glucose Monitoring Survey
Global results show 90% of patients are in favor of a saliva-based glucose test New York, NY, June 7, 2021 – GBS Inc. (Nasdaq: GBS), a life sciences company developing […]
With our world-first Biosensor Platform technology, GBS Inc. will develop and launch two urgently needed non-invasive, real-time diagnostic tests.
Behind the Technology
Meet the team at the Centre for Organic Electronics behind the biosensor technology.
A Member of The iQ Group Global
GBS Inc. is a member of The iQ Group Global, an award-winning consortium of companies that finds, funds and develops innovative bioscience intellectual property from world-class academic institutions to create life-changing medical innovations.
